131I-Nimotuzumab - A potential radioimmunotherapeutic agent in treatment of tumors expressing EGFR

Simple item page
dc.contributor.authorKameswaran, M.
dc.contributor.authorSamuel, G.
dc.contributor.authorSarma, H. D.
dc.contributor.authorShinde, S. N.
dc.contributor.authorDash, A.
dc.contributor.authorVenkatesh, M.
dc.date.accessioned2016-02-04T06:24:40Z
dc.date.available2016-02-04T06:24:40Z
dc.date.issued2015
dc.description.divisionIP&AD;RB&HSDen
dc.format.extent3936 bytes
dc.format.mimetypetext/html
dc.identifier.sourceApplied Radiation & Isotopes, 2015. Vol. 102: pp. 98-102en
dc.identifier.urihttp://hdl.handle.net/123456789/12303
dc.language.isoenen
dc.subjectRadioimmunotherapyen
dc.subject131I-Nimotuzumaben
dc.subjectEGFRen
dc.subjectHead and neck canceren
dc.title131I-Nimotuzumab - A potential radioimmunotherapeutic agent in treatment of tumors expressing EGFRen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0598.htm
Size:
3.84 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2015